Glucosamine now available on prescription

Alateris (glucosamine) is the first prescription-only glucosamine product to receive a licence in the UK for the treatment of mild to moderate osteoarthritis (OA) of the knee.

The efficacy of glucosamine has been assessed in several clinical studies. In two long-term trials, glucosamine was reported to be more effective than placebo in reducing symptoms in patients with mild to moderate OA of the knee. It was also reported to be as effective as ibuprofen in two double-blind randomised four-week studies (n=178 and 200, respectively) in patients with OA of the knee.

Each Alateris tablet contains glucosamine 625mg. The daily dose is two tablets once daily. Relief of symptoms may not be experienced until after several weeks of treatment, and in some cases, even longer. If no relief of symptoms is experienced after two to three months, continued treatment with glucosamine should be re-evaluated.

Further information: Ransom 01462 437615

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases